ACM
NPCE icon

Aquatic Capital Management’s Neuropace NPCE Stock Holding History

Aquatic Capital Management’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$41.4K Sell
3,151
-7,255
-70% -$109K ﹤0.01% 1191
2025
Q4 		$161K Sell
10,406
-11,809
-53% -$158K ﹤0.01% 1045
2025
Q3 		$229K Buy
+22,215
New +$209K ﹤0.01% 1071

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Aquatic Capital Management's NPCE Position: Q1 2026 in Review

Aquatic Capital Management reduced its Neuropace (NPCE) stake by 70% in Q1 2026, selling an estimated $109K and leaving 3,151 shares worth $41.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1191.

Aquatic Capital Management first reported a position in NPCE in Q3 2025 and has held it in 3 quarters since. The position peaked at $229K in Q3 2025. 113 funds tracked by Wall St. Rank hold NPCE as of Q1 2026.

  • Aquatic Capital Management held 3,151 shares of Neuropace worth $41.4K as of Q1 2026.
  • Aquatic Capital Management sold 7,255 Neuropace shares in Q1 2026, an estimated $109K.
  • Neuropace made up ﹤0.01% of Aquatic Capital Management's portfolio in Q1 2026, its #1191 holding.
  • Aquatic Capital Management first reported a position in Neuropace in Q3 2025 and has held it in 3 quarters since.
  • Aquatic Capital Management's Neuropace position peaked at $229K in Q3 2025.
  • 113 funds tracked by Wall St. Rank held Neuropace as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.